The anabolic mechanism of ghrelin is however well recognised and a large proportion of patients included in this pooled analysis had metastatic disease (72%) or severe anorexia–cachexia self‐reported concerns (FAACT A/CS score ≤ 30, 49%). Here, GHRL is linked to metastatic neoplasm.